• Pharnext appoints Amit Kohli as Chief Operating Officer 5/3/2018
• Pharnext Announces that DSMB Recommends Continuing the Ongoing Phase 3 Trial 9/7/2017
• Pharnext to Present PXT864 Data at AAIC 2017 7/11/2017
• Pharnext to Showcase Pioneering PLEOTHERAPY™ R&D Platform 6/21/2017
• Pharnext Announces Strategic Partnership with Tasly 5/10/2017
• Pharnext Reports Year End 2016 Financial Results 4/27/2017
• Pharnext strengthens the position of core shareholders 3/30/2017
• Pharnext to Present New PXT864 Synergy Data at AD/PDTM 2017 3/29/2017
• Pharnext Announces Initiation of Phase 3 Extension Study PLEO-CMT-FU 3/17/2017
• Pharnext intends to Generate a New Pipeline of Synergistic Drug Combinations 3/10/2017